Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Nancy Monroy"'
Autor:
Xóchitl Flores-Ponce, Adolfo López-Ornelas, Itzel Escobedo-Avila, Mayela Rodríguez-Violante, David Dávila-Ortiz de Montellano, Amín Cervantes-Arriaga, Nancy Monroy-Jaramillo, Aurelio Campos-Romo, Iván Velasco
Publikováno v:
Stem Cell Research, Vol 76, Iss , Pp 103337- (2024)
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which results in a prominent reduction of striatal dopamine levels leading to motor alterations. The mechanisms underly
Externí odkaz:
https://doaj.org/article/f7cf76a7c0ad46a8b8ab5ab38baa4cac
Autor:
Xóchitl Flores-Ponce, Adolfo López-Ornelas, Itzel Escobedo-Avila, Mayela Rodríguez-Violante, David Dávila-Ortiz de Montellano, Amín Cervantes-Arriaga, Nancy Monroy-Jaramillo, Iván Velasco
Publikováno v:
Stem Cell Research, Vol 65, Iss , Pp 102972- (2022)
Parkinson’s disease (PD) is a neurodegenerative disease caused by progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which results in motor alterations. The exact mechanisms underlying the dopaminergic neurodegeneration
Externí odkaz:
https://doaj.org/article/191bc08d96374ec18509266393549fab
Autor:
Blanca Estela Pérez-Aldana, José Jaime Martínez-Magaña, Yerye Gibrán Mayén-Lobo, David José Dávila-Ortiz de Montellano, Carlos Luis Aviña-Cervantes, Alberto Ortega-Vázquez, Alma Delia Genis-Mendoza, Emmanuel Sarmiento, Ernesto Soto-Reyes, Isela Esther Juárez-Rojop, Carlos Alfonso Tovilla-Zarate, Thelma Beatriz González-Castro, Humberto Nicolini, Marisol López-López, Nancy Monroy-Jaramillo
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Long-term studies have shown significantly lower mortality rates in patients with continuous clozapine (CLZ) treatment than other antipsychotics. We aimed to evaluate epigenetic age and DNA methylome differences between CLZ-treated patients and those
Externí odkaz:
https://doaj.org/article/b526f0bc169d4ef6a49c9114b2f33af3
Autor:
Constanza García-Delgado, Miguel Angel Noriega-Juárez, Alicia Cervantes, José D Abad-Flores, Mirna Toledo-Bahena, Adriana Valencia-Herrera, Carlos A Mena-Cedillos, América Villaseñor-Domínguez, Adriana Sánchez-Boiso, Yumiko Akaki-Carreño, Blanca Del Río-Navarro, Jesús Aguirre-Hernández, Marisol López-López, Marco Cerbón, Verónica F Morán-Barroso, Nancy Monroy-Jaramillo
Publikováno v:
Dermatologica Sinica, Vol 38, Iss 3, Pp 172-175 (2020)
X-linked hypohidrotic ectodermal dysplasia (XLHED) is caused by EDA pathogenic variants. Female carriers show several clinical manifestations in variable percentages. We studied 11 Mexican heterozygous females with an EDA variant. The most frequent s
Externí odkaz:
https://doaj.org/article/483a1ce9046445dbadc08803a0c8a538
Autor:
Yerye Gibrán Mayén-Lobo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Alma Delia Genis-Mendoza, David José Dávila-Ortiz de Montellano, Ernesto Soto-Reyes, Humberto Nicolini, Marisol López-López, Nancy Monroy-Jaramillo
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 118 (2021)
Clozapine (CLZ) is the only antipsychotic drug that has been proven to be effective in patients with refractory psychosis, but it has also been proposed as an effective mood stabilizer; however, the complex mechanisms of action of CLZ are not yet ful
Externí odkaz:
https://doaj.org/article/1a1bc802fb3544f9a2d09f670c27224d
Autor:
Nancy Monroy-Jaramillo
Publikováno v:
Brazilian Journal of Psychiatry, Vol 39, Iss 3, Pp 274-274
Externí odkaz:
https://doaj.org/article/699a14abd6c6442db7893a88b2fbd623
Publikováno v:
Revista chilena de neuro-psiquiatría. 60:313-324
Autor:
Nancy Monroy-Jaramillo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Janitza Montalvo-Ortiz, Marisol López-López
Publikováno v:
Pharmacogenomics. 23:371-392
Clozapine (CLZ) is an atypical antipsychotic reserved for patients with refractory psychosis, but it is associated with a significant risk of severe adverse reactions (ADRs) that are potentiated with the concomitant use of alcohol. Additionally, phar
Autor:
Nancy Monroy-Jaramillo, Pedro Dorado, Ingrid Fricke-Galindo, Irma Susana Rojas-Tomé, Marisol López-López, Alberto Ortega-Vázquez, Helgi Jung-Cook, Eva M Peñas-Lledó, Iris E. Martínez-Juárez, Adrián LLerena
Publikováno v:
Pharmacogenomics. 22:983-996
Aim: We evaluated the potential influence of genetic ( CYP3A5, EPHX1, NR1I2, HNF4A, ABCC2, RALBP1, SCN1A, SCN2A and GABRA1) and nongenetic factors on carbamazepine (CBZ) response, adverse drug reactions and CBZ plasma concentrations in 126 Mexican Me
Autor:
Gabriela Martinez-Levy, Eli Elier González-Sáenz, Gustavo Turecki, Amalia Gómez-Cotero, Zahia Aouabed, Said Muñoz-Montero, Gary Chen, Daniel Almeida, Claudia Rangel, Consuelo Walss-Bass, Ana Luisa Romero-Pimentel, Nancy Monroy-Jaramillo, Corina Nagy, Humberto Nicolini, Mirna Edith Morales-Marín, Fernando García-Dolores, Roberto Cuauhtemoc Mendoza-Morales, Edith A. Fernández-Figueroa, Jean-François Théroux
Publikováno v:
International Journal of Neuropsychopharmacology
Background Suicide represents a major health concern, especially in developing countries. While many demographic risk factors have been proposed, the underlying molecular pathology of suicide remains poorly understood. A body of evidence suggests tha